Year: 2021
Type: review
Abstract: Metabolic reprogramming enables cancer cell growth, proliferation, and survival. This reprogramming is driven by the combined actions of oncogenic alterations in cancer cells and host cell factors acting on cancer cells in the tumor microenvironment. Cancer cell-intrinsic mechanisms activate signal transduction components that either directly enhance metabolic enzyme activity or upregulate transcription factors that in turn increase expression of metabolic regulators. Extrinsic signaling mechanisms involve host-derived factors that further promote and amplify metabolic reprogramming in cancer cells. This review describes intrinsic and extrinsic mechanisms driving cancer metabolism in the tumor microenvironment and how such mechanisms may be targeted therapeutically. SIGNIFICANCE: Cancer cell metabolic reprogramming is a consequence of the converging signals originating from both intrinsic and extrinsic factors. Intrinsic signaling maintains the baseline metabolic state, whereas extrinsic signals fine-tune the metabolic processes based on the availability of metabolites and the requirements of the cells. Therefore, successful targeting of metabolic pathways will require a nuanced approach based on the cancer's genotype, tumor microenvironment composition, and tissue location.
Source: Cancer Discovery
Authors: Prasenjit Dey, Alec C. Kimmelman, Ronald A. DePinho
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
Awards: Targeting Malic Enzyme 3 as a Synthetic Lethality Target in Pancreatic Cancer, G28276502, G4119534169, UNDERSTANDING THE ROLE OF MDSCS IN CASTRATION-RESISTANT PROSTATE CANCER AND METASTASIS, Targeting malic enzyme 3 as a synthetic lethality target in pancreatic cancer, Identifying Metabolic Dependencies of Pancreatic Cancers, Exploring Collateral Lethality for Development of Cancer Therapeutics, G7788127438, Roswell Park Cancer Center Support Grant, Genetics and Biology of Pancreatic Ductal Adenocarcinoma, Cancer Center Support Grant, Role of type 2 immune response in pancreatic cancer tumorigenesis
OpenAlex ID: W3123473163
